thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - agenți antineoplazici - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
rapibloc 20 mg/2 ml
aop orphan pharmaceuticals ag - austria - landiololum - conc. pt. sol. inj. - 20mg/2ml - agenti betablocanti betablocante selective
clopidogrel sandoz
acino pharma gmbh - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - agenți antitrombotici - clopidogrel este indicat la adulti pentru prevenirea evenimentelor atherothrombotic în: * pacienţii care suferă de infarct miocardic (de la câteva zile până la mai puţin de 35 de zile), ischemica accident vascular cerebral (de la 7 zile până la mai puţin de 6 luni) sau stabilit periferice boală arterială. pentru informații suplimentare vă rugăm să consultați secțiunea 5.
hepatect cp 50 ui/ml
biotest pharma gmbh - germania - imunoglobulina umana anti-hepatita b - sol. perf. - 50 ui/ ml - imunoglobuline imunoglobuline specifice
egiramlon 2,5 mg/2,5 mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 2,5mg/2,5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
egiramlon 5 mg/5 mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 5mg/5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
egiramlon 5 mg/10mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 5mg/10mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
egiramlon 10 mg/5 mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 10mg/5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
egiramlon 10 mg/10 mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 10mg/10mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
rhophylac 300 micrograme/2 ml
csl behring gmbh - germania - imunoglobulina anti-d - sol. inj. in seringa preumpluta - 300micrograme/2ml - imunoglobuline imunoglobuline specifice